X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9) 9
index medicus (8) 8
apoptosis - drug effects (6) 6
cell line, tumor (6) 6
protein kinase inhibitors - pharmacology (5) 5
cml (4) 4
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (4) 4
leukemia, myelogenous, chronic, bcr-abl positive - genetics (4) 4
membrane proteins - genetics (4) 4
antineoplastic agents - pharmacology (3) 3
apoptosis (3) 3
apoptosis regulatory proteins - genetics (3) 3
bh3 mimetic (3) 3
female (3) 3
hemic and lymphatic diseases (3) 3
imatinib (3) 3
male (3) 3
neoplasms (3) 3
piperazines - pharmacology (3) 3
proto-oncogene proteins - genetics (3) 3
pyrimidines - pharmacology (3) 3
sulfonamides - pharmacology (3) 3
abt-199 (2) 2
aged (2) 2
aniline compounds - pharmacology (2) 2
bcl-2-like protein 11 (2) 2
benzamides - pharmacology (2) 2
biological phenomena, cell phenomena, and immunity (2) 2
bridged bicyclo compounds, heterocyclic - pharmacology (2) 2
carcinoma, non-small-cell lung - genetics (2) 2
cell biology (2) 2
core binding factor alpha 3 subunit - genetics (2) 2
core binding factor alpha 3 subunit - metabolism (2) 2
drug resistance, neoplasm (2) 2
drug resistance, neoplasm - drug effects (2) 2
gene deletion (2) 2
gene expression (2) 2
gene expression regulation, neoplastic - drug effects (2) 2
genetic aspects (2) 2
genetic polymorphisms (2) 2
imatinib mesylate (2) 2
kinases (2) 2
lung neoplasms - genetics (2) 2
middle aged (2) 2
neoplastic stem cells - drug effects (2) 2
normal cord blood (2) 2
oncology (2) 2
polymorphism (2) 2
polymorphism, genetic - genetics (2) 2
progenitors (2) 2
proto-oncogene proteins c-bcl-2 - antagonists & inhibitors (2) 2
proto-oncogene proteins c-bcl-2 - metabolism (2) 2
research (2) 2
research paper (2) 2
sequence deletion - genetics (2) 2
tumor stem cell assay (2) 2
abl protein (1) 1
abridged index medicus (1) 1
acetylation (1) 1
activating mutations (1) 1
adenocarcinoma - metabolism (1) 1
adenocarcinoma - pathology (1) 1
adult (1) 1
aged, 80 and over (1) 1
analysis (1) 1
angina (1) 1
angina, stable - epidemiology (1) 1
animals (1) 1
annexins - metabolism (1) 1
antimetabolites, antineoplastic - pharmacology (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
automation & control systems (1) 1
azacitidine - analogs & derivatives (1) 1
azacitidine - pharmacology (1) 1
barium-titanate (1) 1
bcl-2-like protein 11 - genetics (1) 1
bcr protein (1) 1
bcr-abl1 (1) 1
benzimidazoles - pharmacology (1) 1
bh3 interacting domain death agonist protein - genetics (1) 1
bim deletion polymorphism (1) 1
bim protein (1) 1
biochemistry (1) 1
biochemistry & molecular biology (1) 1
biology (1) 1
biology and life sciences (1) 1
biotechnology (1) 1
biphenyl compounds - pharmacology (1) 1
breast neoplasms - drug therapy (1) 1
breast neoplasms - genetics (1) 1
breast neoplasms - metabolism (1) 1
cancer (1) 1
cancer cells (1) 1
cancer therapies (1) 1
cancers and neoplasms (1) 1
carcinoma, non-small-cell lung - drug therapy (1) 1
cardiac & cardiovascular systems (1) 1
cardiovascular diseases (1) 1
cardiovascular diseases - mortality (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Research, ISSN 0008-5472, 04/2012, Volume 72, Issue 8 Supplement, pp. 4958 - 4958
Journal Article
Nature Medicine, ISSN 1078-8956, 04/2012, Volume 18, Issue 4, pp. 521 - 528
Tyrosine kinase inhibitors (TKIs) elicit high response rates among individuals with kinase-driven malignancies, including chronic myeloid leukemia (CML) and... 
CHRONIC MYELOGENOUS LEUKEMIA | MEDICINE, RESEARCH & EXPERIMENTAL | APOPTOSIS | GEFITINIB | BIOCHEMISTRY & MOLECULAR BIOLOGY | EYE DISEASES | CHRONIC MYELOID-LEUKEMIA | CELL BIOLOGY | CELL LUNG-CANCER | FACTOR RECEPTOR EGFR | GROWTH | ACTIVATING MUTATIONS | MUTANT EGFR | Enzyme-Linked Immunosorbent Assay - methods | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Follow-Up Studies | Apoptosis - drug effects | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | BH3 Interacting Domain Death Agonist Protein - genetics | Dose-Response Relationship, Drug | Protein Isoforms - metabolism | Transfection | Bcl-2-Like Protein 11 | Statistics, Nonparametric | Aged, 80 and over | Apoptosis Regulatory Proteins - genetics | Adult | Female | Gene Expression Regulation, Neoplastic - drug effects | Lung Neoplasms - genetics | Annexins - metabolism | Carcinoma, Non-Small-Cell Lung - genetics | Membrane Proteins - genetics | Gene Frequency | Exons - genetics | Genotype | Proto-Oncogene Proteins - genetics | International Cooperation | Drug Resistance, Neoplasm - genetics | Cell Line, Tumor | Polymorphism, Genetic - genetics | Aged | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Cohort Studies | Drug Resistance, Neoplasm - drug effects | Protein Isoforms - genetics | RNA, Small Interfering - metabolism | Sequence Deletion - genetics | Antimitotic agents | Physiological aspects | Protein tyrosine kinase | Dosage and administration | Genetic aspects | Research | Antineoplastic agents | Tumor proteins | Genetic polymorphisms | Inhibitor drugs | Mutation | Kinases | Gene expression | Apoptosis | Polymorphism | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2017, Volume 12, Issue 3, pp. e0174107 - e0174107
Chronic myeloid leukemia (CML) treatment has been improved by tyrosine kinase inhibitors (TKIs) such as imatinib mesylate (IM) but various factors can cause... 
CELLS | DOMAIN | CML | THERAPY | ACETYLATION | MULTIDISCIPLINARY SCIENCES | IMATINIB | HISTONE DEACETYLASE INHIBITORS | COMBINATION | CANCER | CHAPERONE FUNCTION | Apoptosis - drug effects | Humans | Enzyme Inhibitors - pharmacology | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Bcl-2-Like Protein 11 - genetics | RNA Splicing | Gene Deletion | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Fusion Proteins, bcr-abl - antagonists & inhibitors | K562 Cells | Benzimidazoles - pharmacology | Histone Deacetylase Inhibitors - pharmacology | Antineoplastic Agents - pharmacology | Care and treatment | Analysis | Genetic aspects | Chronic myeloid leukemia | Research | Risk factors | Genetic polymorphisms | Cancer | BCR protein | Biotechnology | Histone deacetylase | Chromatin | Substance abuse treatment | Leukemia | Lung cancer | Biology | mRNA | Gene deletion | Kinases | Gene polymorphism | Cancer therapies | Medical schools | Proteins | Clonal deletion | Rodents | Deletion | Fusion protein | Growth factors | Protein-tyrosine kinase | Tyrosine | Medical research | Imatinib | Immunoglobulins | Hematology | Splicing | Review boards | Myeloid leukemia | Hydroxamic acid | Abl protein | Pharmacology | Gene expression | Patients | Resistance factors | Hospitals | Inhibitors | Cell death | Cell lines | Isoforms | Stem cells | Viability | BIM protein | Apoptosis | Polymorphism | Index Medicus
Journal Article
Oncotarget, ISSN 1949-2553, 2014, Volume 5, Issue 19, pp. 9033 - 9038
BCR-ABL1-specific tyrosine kinase inhibitors prolong the life of patients with chronic myeloid leukemia (CML) but cannot completely eradicate CML progenitors.... 
Imatinib | CML | Progenitors | Normal cord blood | ABT-199 | BH3 mimetic | Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article
Journal of Physics and Chemistry of Solids, ISSN 0022-3697, 06/2018, Volume 117, pp. 148 - 157
We have investigated in detail the lattice dynamics of five different perovskite titanates ATiO (A = Ca, Sr, Ba, Pb, Eu) where the A sites are occupied by +2... 
Perovskites | Precursor effects | Ferroelectricity | Phase transitions | LATTICE-DYNAMICS | PHYSICS, CONDENSED MATTER | CRYSTAL STABILITY | EDGE FINE-STRUCTURE | OPTICAL-PROPERTIES | LOCAL-STRUCTURE | BARIUM-TITANATE | CHEMISTRY, MULTIDISCIPLINARY | STRONTIUM-TITANATE | Perovsldtes | FERROELECTRIC PHASE-TRANSITION | ORDER-DISORDER | ELECTRONIC-STRUCTURE
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.